Interested in specific Information?

Filter what you see here

Patients eligible for transplant

Validation of the R-ISS for stratification of transplant-eligible MM…

Validation of the R-ISS for stratification of transplant-eligible MM patients

Apr 19, 2018

General MM

Detection of MM-associated translocations and mutations in IGLL5

Apr 17, 2018

General MM

Treatment to suppression of focal lesions in NDMM is an important…

Apr 17, 2018

Relapsed/refractory patients

Selinexor receives FDA fast track designation 

Selinexor receives FDA fast track designation 

Apr 13, 2018

General MM

High BMI in early and late adulthood is a risk factor for MM

Apr 12, 2018

General MM,   Relapsed/refractory patients,  Patients eligible for transplant

Denosumab approved for MM in Europe

Apr 11, 2018

Relapsed/refractory patients

Response kinetics and treatment outcomes in RRMM

Response kinetics and treatment outcomes in RRMM

Apr 9, 2018

Patients eligible for transplant

EBMT 2018 | Pre-transplant Induction in MM

Apr 5, 2018

Elderly patients

EMBT 2018 | Therapies for fit, elderly MM patients

Apr 3, 2018

General MM,   Patients eligible for transplant,  Patients non-eligible for transplant,   & 1 more

Following NICE guidelines | An interview with Ceri Bygrave

Following NICE guidelines | An interview with Ceri Bygrave

Mar 29, 2018

Patients eligible for transplant

EBMT 2018 | Galinpepimut-S (GPS) vaccine in high-risk MM

Mar 27, 2018

Patients eligible for transplant

EBMT 2018 | Efficacy and safety of bortezomib in allogeneic-transplant for…

Mar 23, 2018

Prof. Mohamad Mohty | EBMT 2018 | Role of double auto-transplant in…

Prof. Mohamad Mohty | EBMT 2018 | Role of double auto-transplant in Multiple Myeloma

Mar 22, 2018

General MM

EBMT 2018 | Cost-effectiveness of modern MM therapies

Mar 21, 2018

General MM

EBMT 2018 | CD229 is a promising target for MM

Mar 19, 2018
prev
next

Latest Medical Information

Latest Expert Opinions

General MM,Patients eligible for transplant,Patients non-eligible for transplant,Relapsed/refractory patients

Following NICE guidelines | An interview with Ceri Bygrave

Mar 29, 2018
English & Spanish

Latest Biology

Latest Drug Updates

Relapsed/refractory patients

Orphan drug designation granted to PT-112

Feb 14, 2018
Patients non-eligible for transplant

Daratumumab (darzalex) granted Priority Review as a frontline regimen

Jan 22, 2018

Recently updated Licenses

Where we are next

The 4th World Congress on CONTROVERSIES IN MULTIPLE MYELOMA (COMy)

May 3-5, 2018 | Paris, France

The Multiple Myeloma Hub will be attending the 2018 Controversies in Multiple Myeloma meeting in Paris from 3-5 May 2018. Some of the biggest names in Multiple Myeloma will gather together to discuss the latest advances in treatment and guidelines for disease management, in the form of talks, case studies, and active debate. Stay tuned to the MM Hub to follow for our first-hand coverage.

Event Website

Map Data
Map data ©2018 Google
Map DataMap data ©2018 Google
Map data ©2018 Google

Connect with us

Our sister hubs

Visit our other community physician education hubs in haematology and oncology